Heart Racing When You Stand? POTS, MCAS and Histamine in Perimenopause

← Back to Blog

Your heart pounds every time you get up from the couch. You flush for no obvious reason. You have started reacting to foods you used to eat without a second thought. You feel wired and bone tired at the same time. And every time you mention these symptoms, someone suggests anxiety, or tells you it is just perimenopause.

This post is for you.

Two conditions are significantly underdiagnosed in perimenopausal women: POTS (Postural Orthostatic Tachycardia Syndrome) and MCAS (Mast Cell Activation Syndrome). Both are more common than most people realise, both are frequently missed or misattributed to anxiety, and both are strongly influenced by the hormonal changes of perimenopause. Histamine is central to both. So is the exhaustion of being told, for years, that nothing is wrong.

This is not a post about diagnosing yourself. It is about understanding a pattern that, once you see it, is hard to unsee.

What is POTS?

POTS stands for Postural Orthostatic Tachycardia Syndrome. It is a dysfunction of the autonomic nervous system, the part of your nervous system that quietly runs your heart rate, blood pressure, digestion, temperature regulation, and breathing in the background. When it works well, you barely notice it. When it does not, everything feels effortful.

With POTS, when you move from lying or sitting to standing, your heart rate surges more than it should. The clinical threshold is a rise of 30 beats per minute or more within 10 minutes of standing, without a significant drop in blood pressure. Women describe it as a heart that pounds or races when they get up, dizziness or lightheadedness on standing, brain fog, fatigue, nausea, difficulty standing for any length of time, and sometimes near-fainting.

Other symptoms include blurred vision, headaches (often including migraines), digestive problems such as bloating and nausea, temperature dysregulation, and extreme fatigue that worsens with upright activity. The Australian POTS Foundation describes this well: the autonomic nervous system is your body's autopilot, and when it is off balance, the ripple effects are wide.

POTS is significantly more common in women. Research suggests women are around five times more likely to be diagnosed than men, and the condition most commonly appears between puberty and around age 50, which puts perimenopausal women squarely in the frame.

Established Diagnosis is based on a heart rate increase of 30 bpm or more on standing, symptoms persisting for at least three months, with no other explanation for the tachycardia. A simple Active Stand Test, sometimes called the NASA Lean Test, can be done at your GP clinic as a starting point before specialist referral.

What is MCAS?

MCAS stands for Mast Cell Activation Syndrome. Mast cells are immune cells found throughout the body, particularly in skin, gut, lungs, and the tissue surrounding blood vessels. Their normal job is to respond to perceived threats by releasing chemical messengers, the most well known being histamine. With MCAS, mast cells become overactive or are triggered too easily, releasing these chemicals in situations where they should not.

The result is a wide and seemingly random range of symptoms that can affect almost any system: flushing, hives or rashes, itching, heart palpitations, low blood pressure, digestive upset (nausea, cramping, bloating, diarrhoea), brain fog, headaches, anxiety, and reactions to foods, heat, stress, exercise, chemicals, or medications that can appear to come from nowhere. Many women describe suddenly becoming reactive to things they have always tolerated. This unpredictability is part of what makes MCAS so disorienting.

The Australasian Mastocytosis Society (TAMS) recognises three subtypes of MCAS in Australia: primary (involving clonal or genetically abnormal mast cells), secondary (where an underlying condition drives mast cell overactivation), and idiopathic (where no clear trigger is found). For most women navigating perimenopause with suspected MCAS, secondary MCAS is the most relevant category, with hormonal changes acting as the driver.

MCAS is genuinely difficult to diagnose. Symptoms vary considerably between people, can come and go unpredictably, and overlap with many other conditions including anxiety, irritable bowel syndrome, and perimenopause itself. TAMS notes that many patients initially suspected of having MCAS are ultimately found to have other conditions, which is why specialist assessment matters.

Histamine: The Molecule That Links It All

Histamine is the key chemical connecting POTS, MCAS, and much of what perimenopause seems to amplify. If you are not yet familiar with how histamine works in the body, the histamine intolerance and perimenopause post covers the oestrogen connection in more detail. Here we will focus specifically on how histamine feeds into both MCAS and POTS.

When mast cells release histamine and other inflammatory mediators, blood vessels dilate. Vasodilation reduces the blood volume returning to the heart and brain when you are upright, which is precisely the mechanism that drives POTS symptoms. In other words, mast cell activation and histamine release can directly worsen postural tachycardia, or trigger episodes in someone who already has POTS.

Emerging Research also points to a bidirectional relationship between the autonomic nervous system and mast cell activity. When vagal tone (the parasympathetic, calming branch of the autonomic nervous system) is low, the anti-inflammatory signal it normally provides is weakened. This can increase mast cell reactivity. So POTS can worsen MCAS, and MCAS can worsen POTS. The two conditions can drive each other in a cycle that is hard to break without addressing both.

The practical implication matters: if you have both POTS and MCAS, it makes sense to work on reducing your mast cell reactivity and histamine load before significantly increasing your exercise intensity, since vigorous exercise is itself a known mast cell trigger for some people.

Why Perimenopause Makes Both Conditions Worse

This is where oestrogen comes in, and it is more specific than most people expect.

Mast cells are not passive bystanders during hormonal shifts. They carry oestrogen receptors (both ERalpha and ERbeta), meaning they directly sense and respond to changes in oestrogen levels. Research shows that oestrogen can activate mast cells through a rapid pathway, triggering the release of histamine and other inflammatory mediators. Progesterone, on the other hand, tends to have a calming effect on mast cell activity.

In early perimenopause, progesterone typically drops first, before oestrogen does. Losing that calming influence can make mast cells more reactive. As perimenopause progresses and oestrogen levels begin to spike and dip in unpredictable patterns, each spike can trigger a fresh wave of mast cell activation and histamine release. For women who already have a tendency towards MCAS or histamine sensitivity, this hormonal volatility can be what tips them from manageable to overwhelming.

The autonomic nervous system is similarly affected. Studies in POTS patients show that symptoms worsen during the premenstrual and early follicular phases of the cycle, when both oestrogen and progesterone are at their lowest. The renin-angiotensin-aldosterone system, which helps regulate blood volume, is also influenced by hormonal shifts, contributing to the low blood volume and the "empty tank" sensation that many women with POTS describe.

Established Oestrogen and progesterone directly influence mast cell behaviour, and autonomic nervous system function fluctuates across the hormonal cycle.

Emerging The specific trajectory of POTS symptoms across the perimenopause transition is an active area of research. Importantly, once hormones stabilise after menopause, some women find their POTS symptoms actually improve. The perimenopause transition itself is often the most difficult phase, not because something is permanently broken, but because the system is managing a significantly increased load.

Why It Takes So Long to Get a Diagnosis

The diagnostic delay for POTS is one of the most striking things about this condition. According to Dysautonomia International, the average wait from first symptoms to diagnosis is five years and eleven months. During that time, patients see an average of seven different doctors. Approximately 69% are diagnosed with an anxiety disorder before their POTS is identified.

For women, the wait is longer still. Research shows women wait an average of seven years for a POTS diagnosis, compared to 3.8 years for men. Women are 2.6 times more likely to receive a mental health treatment plan instead of investigation for an autonomic condition. Nearly 60% are explicitly told their symptoms are all in their head.

MCAS carries a similar history. The diversity and unpredictability of its symptoms means it is regularly attributed to anxiety, food allergy, hormonal imbalance, or irritable bowel syndrome, without the mast cell mechanism being explored.

The fact that both conditions worsen during perimenopause, a time when women are already frequently told that everything is "just hormones," adds another layer to the difficulty of being taken seriously. A racing heart and dizziness on standing look like anxiety from the outside. Flushing and random reactions to food look like perimenopause. The physical reality underneath can remain uninvestigated for years.

If you have been dismissed and you recognise this pattern, your symptoms deserve proper investigation.

What the Research Supports for Management

Both POTS and MCAS respond to non-pharmaceutical strategies, though what helps depends on your individual picture and ideally involves a clinician with relevant experience. Here is what the evidence supports.

For POTS

First-line management for POTS focuses on increasing blood volume and reducing the orthostatic stress on your cardiovascular system:

• Fluid intake of 2 to 3 litres per day, spread consistently across the day
• Salt intake of up to 10 grams per day, under medical supervision, to help retain fluid and expand blood volume
• Medical-grade compression garments from ankle to waist, at 20 mmHg or above, which reduce blood pooling in the lower body
• Avoiding common triggers: heat, prolonged standing, large meals, alcohol, and caffeine
• Movement that starts with non-upright exercise such as recumbent cycling, rowing, or swimming, before progressing to upright aerobic activity over time
• Physical counter-manoeuvres during acute episodes, including leg crossing, squatting, or tensing the leg muscles to push blood back towards the heart

Established Fluid, salt, and compression are first-line non-pharmaceutical interventions for POTS, supported by clinical guidelines. Note that in Australia, all POTS medications are currently off-label and are not subsidised by the PBS. Medication decisions require specialist oversight.

For MCAS and Histamine Load

• Identifying your personal triggers (specific foods, heat, stress, exercise, fragrances, medications) and working to reduce your total load rather than eliminating everything at once
• Dietary adjustments during flares, including a lower-histamine approach in the short term (the histamine intolerance post covers practical food guidance)
• Nervous system regulation techniques that activate the vagus nerve: slow diaphragmatic breathing, humming or singing, gentle cold water on the face, and mindfulness practices
• Stabilising mast cell reactivity before significantly increasing exercise load, particularly if exercise is a known trigger

For Both

• Pacing: managing your activity relative to your current capacity, not what you could do before symptoms appeared
• Sleep protection: consistent sleep timing, a cool and dark room, and reduced evening demands have a disproportionate effect on both autonomic stability and mast cell behaviour
• Reducing overall inflammatory load through stable nutrition, stress management, and trigger awareness

No current evidence Menopausal hormone therapy (MHT/HRT) does not currently have evidence for treating POTS directly. It may still be appropriate for other menopausal indications such as sleep, bone health, and vasomotor symptoms, and the reduction in hormonal volatility may indirectly benefit some women. This is a conversation for your doctor.

Who Can Help

One of the most common frustrations with POTS and MCAS is that different specialists see their piece of the puzzle without anyone holding all of it together. A cardiologist may investigate the heart rate but not the mast cells. An allergist may work on the reactions but not the autonomic instability. Your GP may refer you on without connecting either to perimenopause.

Thyroid function, iron studies, and a cardiovascular assessment are usually sensible first steps to rule out other contributors before pursuing specialist referral. The Australian POTS Foundation clinician directory lists practitioners with specific POTS experience, including in New South Wales.

Alongside medical investigation, nurse-led coaching with a background in perimenopause and complex conditions can support you to understand what you are dealing with, track your symptom patterns, prepare for specialist appointments, and build the lifestyle foundation that underpins everything else. It is not a replacement for medical care. It is the structure that helps you get the most from it.